Koefisien rega marang bathi Beam Tx (BEAM)

Lambang korporat lan logo Beam Therapeutics Inc (BEAM)

The patent monopoly on the treatment of genetic pathologies provides Beam Therapeutics Inc. (BEAM) with a stable income stream, which is supported by the company's estimated P/E. The partnership with Pfizer accelerates the development of precision therapies, while a neutral geopolitical environment in the US and EU ensures business stability. The current metric stands at -22.40, allowing for an objective comparison of the share price against the issuer's actual earnings.

Beam Tx (BEAM) - Koefisien rega marang bathi saka 04.07.2022 nganti 15.11.2026

Rincian metrik komprehensif lan analitis Beam Therapeutics Inc (BEAM)

Analisis komprehensif perusahaan:Beam Therapeutics - BEAM
Barang unggulan Beam Therapeutics

The P/E ratio compares a business's market value to its net income, allowing investors to determine the extent of an asset's overvaluation and estimate the investment's payback period. By analyzing the quarterly P/E of Beam Therapeutics Inc. (BEAM), an investor can see how risks of technological nationalism and patent disputes impact the capitalization of Beam Therapeutics Inc. (BEAM), which is critical for verifying the fundamental stability of this biopharmaceutical issuer.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Sarepta Therapeutics, Inc. (SRPT) - Pangali P/E|TWST (twistbioscience.com) - Pangali P/E|10x Genomics, Inc. (TXG) - Periode bali modal bisnis|Koefisien rega marang bathi NTLA (Intellia Therapeutics, Inc.)|STOK - Kapitalisasi marang bathi|Rasio rega marang bathi biolifesolutions.com BLFS|Periode bali modal bisnis Wave Life Sciences Corp (WVE)|MAZE - Rasio rega marang bathi|Nilai perusahaan marang bathi resik SION (Sionna Therapeutics Inc)|PRME: Pangali P/E|Taysha - Nilai perusahaan marang bathi resik|Rasio rega marang bathi uniQure NV|Pangali rega marang bathi MGTX (MeiraGTx PLC)|Koefisien rega marang bathi RGNX (regenxbio.com)|Solid Biosciences Inc. - Pangali rega marang bathi|Rasio rega marang bathi Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi